(PDF) BCL-2 Protein Does Not Help to Distinguish Benign

BCL-2 Protein Does Not Help to Distinguish Benign From Malignant Lymphoid Nodules in Bone Marrow Biopsy Specimens.

Journal of Clinical Pathology - United Kingdom

doi 10.1136/jcp.50.1.87-b

Full Text

Abstract

Available in full text

Categories

Forensic Medicine

Date

January 1, 1997

Authors

Publisher

BMJ

Related search

Signaling Pathways Influencing Tumor Microenvironment and Their Exploitation for Targeted Drug Delivery

English

Tumor-Targeted Drug Delivery With Aptamers

Current Medicinal Chemistry

Organic Chemistry

Molecular Medicine

English

A Cooperative Polymeric Platform for Tumor-Targeted Drug Delivery

Chemical Science

English

Tumor Homing and Penetrating Peptide-Conjugated Niosomes as Multi-Drug Carriers for Tumor-Targeted Drug Delivery

Chemical Engineering

English

Advances in Receptor-Mediated, Tumor-Targeted Drug Delivery

Advanced Therapeutics

Pharmaceutical Science

English

Synthesis and Evaluation of Doxorubicin-Loaded Gold Nanoparticles for Tumor-Targeted Drug Delivery

English

Hybrid Quantum Dot-Based Theranostic Nanomedicines for Tumor-Targeted Drug Delivery and Cancer Imaging

Materials Science

Biomedical Engineering

English

Physico-Chemical Strategies to Enhance Stability and Drug Retention of Polymeric Micelles for Tumor-Targeted Drug Delivery

Macromolecular Bioscience

Materials Chemistry

English

Nanocarriers for Magnetically Actuated Targeted Drug Delivery

Biophysical Journal

English

Capillary Collagen as the Physical Transport Barrier in Drug Delivery to Tumor Microenvironment

Tissue Barriers

English